^@&(@**&^@*(*^&*&*(@*&(&*YI#)*IY(&*(#(Y*)@(_@#&&#(*O_P{L|}?Q":OP!W#@10/29/2026,
y and Alternative
ChapterTherapies
5_ Complementary
(1).pdf!*^@&(@**&^@*(*^&*&*(@*&(&*YI#)*IY(&*(#(Y*)@(_@#&&#(*O_P{L|}?Q":OP!W#@10/29/2026,
and Alternative Therapies (1).pdf!*^@&(@**&^@*(*^&*&*(@*&(&*YI#)*IY(&*(#(Y*)@(_@#&&#(*O_P{L|}?Q":OP!W#@10/29/2026,
1:43:28 PMChapter 5_ Complementary
1:43:28
and Alternative
PMChapterTherapies
5_ Complementary
(1) 1:43:2
an
STUVIA 2024/2025
Chapter 5: Complementary and Alternative
Therapies
A family member expresses concern that a patient is taking several herbal remedies and worries that
they may be unsafe. The nurse will respond by saying that herbal products:
a. are classified as medications by the Dietary Supplement Health and Education Act of 1994.
b. are regulated by the government and are determined to be safe.
c. aren't usually effective but are generally harmless.
d. should be discussed with the patient's provider in conjunction with other
medications. - ✔✔ANS: D
Herbs are sometimes useful but can also be useless or dangerous. There are no agencies that
regulate safety and efficacy. Patients should always tell providers if they are taking any herbal
remedies since there are known drug-herbal interactions and side effects.
A patient asks the nurse about an herbal supplement and reports that it has a United States
Pharmacopeia (USP) seal of approval. The nurse explains that this indicates:
a. identity, potency, purity, and labeling accuracy.
b. premarket testing for safety and efficacy.
%
c. structure and function claims may be made.
d. the supplement's ability to prevent and treat disease. - ✔✔ANS: A
The USP "seal of approval" indicates accuracy of the products identity, potency, purity, and labeling. It
does not indicate premarket research on safety and accuracy, does not allow manufacturers to make
claims about the function of the products, and does not indicate the substance's ability to prevent and
treat disease.
A patient asks the nurse about the safety of herbal products in general. Which response by the nurse
is correct?
a. "Consumers should research products and their manufacturers before taking."
b. "Manufacturers are required to list interactions of herbs with drugs and food."
c. "Products manufactured for drug and grocery store chains are safe."
d. "Toxicological analysis is required of all commercial herbal products." - ✔✔ANS: A
There are no comprehensive regulations of herbal supplements regarding safety and efficacy, so
consumers should research herbs and product manufacturers. Companies manufacturing for drug
and grocery stores are suspect and do not always list all ingredients on their labels.
stuvia
^@&(@**&^@*(*^&*&*(@*&(&*YI#)*IY(&*(#(Y*)@(_@#&&#(*O_P{L|}?Q":OP!W#@10/29/2026,
1)ChapterChapter
5_ Complementary
5_ Complementary
and Alternative
and Alternative
Therapies
Therapies
(1).pdf!*^@&(@**&^@*(*^&*&*(@*&(&*YI#)*IY(&*(#(Y*)@(_@#&&#(*O_P{L|}?Q":OP!W#@10/29/2026,
(1).pdf!*^@&(@**&^@*(*^&*&*(@*&(&*YI#)*IY(&*(#(Y*)@(_@#&&#(*O_P{L|}?Q":OP!W#@10/29/2026,
1:43:28 PMChapter 5_ Complementary and Alternative Therapies1:43:28
(1) 1:43:2
PMC
y and Alternative
ChapterTherapies
5_ Complementary
(1).pdf!*^@&(@**&^@*(*^&*&*(@*&(&*YI#)*IY(&*(#(Y*)@(_@#&&#(*O_P{L|}?Q":OP!W#@10/29/2026,
and Alternative Therapies (1).pdf!*^@&(@**&^@*(*^&*&*(@*&(&*YI#)*IY(&*(#(Y*)@(_@#&&#(*O_P{L|}?Q":OP!W#@10/29/2026,
1:43:28 PMChapter 5_ Complementary
1:43:28
and Alternative
PMChapterTherapies
5_ Complementary
(1) 1:43:2
an
STUVIA 2024/2025
Chapter 5: Complementary and Alternative
Therapies
A family member expresses concern that a patient is taking several herbal remedies and worries that
they may be unsafe. The nurse will respond by saying that herbal products:
a. are classified as medications by the Dietary Supplement Health and Education Act of 1994.
b. are regulated by the government and are determined to be safe.
c. aren't usually effective but are generally harmless.
d. should be discussed with the patient's provider in conjunction with other
medications. - ✔✔ANS: D
Herbs are sometimes useful but can also be useless or dangerous. There are no agencies that
regulate safety and efficacy. Patients should always tell providers if they are taking any herbal
remedies since there are known drug-herbal interactions and side effects.
A patient asks the nurse about an herbal supplement and reports that it has a United States
Pharmacopeia (USP) seal of approval. The nurse explains that this indicates:
a. identity, potency, purity, and labeling accuracy.
b. premarket testing for safety and efficacy.
%
c. structure and function claims may be made.
d. the supplement's ability to prevent and treat disease. - ✔✔ANS: A
The USP "seal of approval" indicates accuracy of the products identity, potency, purity, and labeling. It
does not indicate premarket research on safety and accuracy, does not allow manufacturers to make
claims about the function of the products, and does not indicate the substance's ability to prevent and
treat disease.
A patient asks the nurse about the safety of herbal products in general. Which response by the nurse
is correct?
a. "Consumers should research products and their manufacturers before taking."
b. "Manufacturers are required to list interactions of herbs with drugs and food."
c. "Products manufactured for drug and grocery store chains are safe."
d. "Toxicological analysis is required of all commercial herbal products." - ✔✔ANS: A
There are no comprehensive regulations of herbal supplements regarding safety and efficacy, so
consumers should research herbs and product manufacturers. Companies manufacturing for drug
and grocery stores are suspect and do not always list all ingredients on their labels.
stuvia
^@&(@**&^@*(*^&*&*(@*&(&*YI#)*IY(&*(#(Y*)@(_@#&&#(*O_P{L|}?Q":OP!W#@10/29/2026,
1)ChapterChapter
5_ Complementary
5_ Complementary
and Alternative
and Alternative
Therapies
Therapies
(1).pdf!*^@&(@**&^@*(*^&*&*(@*&(&*YI#)*IY(&*(#(Y*)@(_@#&&#(*O_P{L|}?Q":OP!W#@10/29/2026,
(1).pdf!*^@&(@**&^@*(*^&*&*(@*&(&*YI#)*IY(&*(#(Y*)@(_@#&&#(*O_P{L|}?Q":OP!W#@10/29/2026,
1:43:28 PMChapter 5_ Complementary and Alternative Therapies1:43:28
(1) 1:43:2
PMC
